NCT01997905View on ClinicalTrials.gov

Stroke Feasibility Study

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

July 31, 2015

Study Completion Date

August 31, 2015

Conditions
Atrial FibrillationAFib
Interventions
DEVICE

AtriClip LAA Exclusion Device

Trial Locations (7)

22908

University of Virginia, Charlottesville

33133

Mercy Hospital, Miami

45220

Good Samaritan Hospital, Cincinnati

46237

Franciscan St. Francis Health, Indianapolis

54401

Aspirus, Wausau

77030

Houston Methodist Hospital, Houston

94574

St. Helena Hospital, St. Helena

Sponsors

Lead Sponsor

AtriCure, Inc.
All Listed Sponsors
lead

AtriCure, Inc.

INDUSTRY